Slate Path Capital »

Tvardi Therapeutics shares owned by Slate Path Capital

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Slate Path Capital from 13F filings

Historical chart of Slate Path Capital investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Slate Path Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Slate Path Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $27M 704k 38.97
2025-06-30 $16M 704k 23.33